When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
APRE - Aprea Therapeutics Cancer Therapy Platform Is Promising
Aprea Therapeutics Inc.
Aprea Therapeutics (APRE) is a clinical stage biotechnology company with a promising cancer drug that is in a Phase 3 study that should report out preliminary data late in 2020. If the drug, eprenetapopt, shows positive results, it could get approved by regulatory agencies and, with further trials, get its label expanded to other cancers. Aprea's stock has only been available for public purchase since its IPO in October 2019.
Because I had bought a considerable (for me) amount of Inovio (INO) for as low as $2.43 in 2019, and it